» Articles » PMID: 27298311

Reactive Astrocytes Potentiate Tumor Aggressiveness in a Murine Glioma Resection and Recurrence Model

Overview
Journal Neuro Oncol
Specialties Neurology
Oncology
Date 2016 Jun 15
PMID 27298311
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Surgical resection is a universal component of glioma therapy. Little is known about the postoperative microenvironment due to limited preclinical models. Thus, we sought to develop a glioma resection and recurrence model in syngeneic immune-competent mice to understand how surgical resection influences tumor biology and the local microenvironment.

Methods: We genetically engineered cells from a murine glioma mouse model to express fluorescent and bioluminescent reporters. Established allografts were resected using image-guided microsurgery. Postoperative tumor recurrence was monitored by serial imaging, and the peritumoral microenvironment was characterized by histopathology and immunohistochemistry. Coculture techniques were used to explore how astrocyte injury influences tumor aggressiveness in vitro. Transcriptome and secretome alterations in injured astrocytes was examined by RNA-seq and Luminex.

Results: We found that image-guided resection achieved >90% reduction in tumor volume but failed to prevent both local and distant tumor recurrence. Immunostaining for glial fibrillary acidic protein and nestin showed that resection-induced injury led to temporal and spatial alterations in reactive astrocytes within the peritumoral microenvironment. In vitro, we found that astrocyte injury induced transcriptome and secretome alterations and promoted tumor proliferation, as well as migration.

Conclusions: This study demonstrates a unique syngeneic model of glioma resection and recurrence in immune-competent mice. Furthermore, this model provided insights into the pattern of postsurgical tumor recurrence and changes in the peritumoral microenvironment, as well as the impact of injured astrocytes on glioma growth and invasion. A better understanding of the postsurgical tumor microenvironment will allow development of targeted anticancer agents that improve surgery-mediated effects on tumor biology.

Citing Articles

Fluorescence-Guided Resection of GL261 Red-FLuc and TRP-mCherry-FLuc Mouse Glioblastoma Tumors.

Rodgers L, Maloney B, Hartz A, Bauer B Cancers (Basel). 2025; 17(5).

PMID: 40075583 PMC: 11898961. DOI: 10.3390/cancers17050734.


Distant origin of glioblastoma recurrence: neural stem cells in the subventricular zone serve as a source of tumor reconstruction after primary resection.

Li X, Kim H, Yoo J, Lee Y, Nam C, Park J Mol Cancer. 2025; 24(1):64.

PMID: 40033380 PMC: 11877783. DOI: 10.1186/s12943-025-02273-2.


Tailoring glioblastoma treatment based on longitudinal analysis of post-surgical tumor microenvironment.

Bastiancich C, Snacel-Fazy E, Fernandez S, Robert S, Stacchini R, Plantureux L J Exp Clin Cancer Res. 2024; 43(1):311.

PMID: 39605004 PMC: 11603899. DOI: 10.1186/s13046-024-03231-4.


Modifying Post-Surgical Immunity: Controlled Release of TLR7/8 Agonist for Immune Mediated Clearance of Glioblastoma.

Ainslie K Res Sq. 2024; .

PMID: 39399681 PMC: 11469459. DOI: 10.21203/rs.3.rs-5024510/v1.


Concurrent Oncolysis and Neurolesion Repair by Dual Gene-Engineered hNSCs in an Experimental Model of Intraspinal Cord Glioblastoma.

Zeng X, Ropper A, Aljuboori Z, Yu D, Teng T, Kabatas S Cells. 2024; 13(18.

PMID: 39329707 PMC: 11429792. DOI: 10.3390/cells13181522.


References
1.
Myer D, Gurkoff G, Lee S, Hovda D, Sofroniew M . Essential protective roles of reactive astrocytes in traumatic brain injury. Brain. 2006; 129(Pt 10):2761-72. DOI: 10.1093/brain/awl165. View

2.
Minniti G, De Sanctis V, Muni R, Filippone F, Bozzao A, Valeriani M . Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients. J Neurooncol. 2008; 88(1):97-103. DOI: 10.1007/s11060-008-9538-0. View

3.
Quail D, Joyce J . Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013; 19(11):1423-37. PMC: 3954707. DOI: 10.1038/nm.3394. View

4.
Schmid R, Simon J, Vitucci M, McNeill R, Bash R, Werneke A . Core pathway mutations induce de-differentiation of murine astrocytes into glioblastoma stem cells that are sensitive to radiation but resistant to temozolomide. Neuro Oncol. 2016; 18(7):962-73. PMC: 4896545. DOI: 10.1093/neuonc/nov321. View

5.
Hou L, Veeravagu A, Hsu A, Tse V . Recurrent glioblastoma multiforme: a review of natural history and management options. Neurosurg Focus. 2006; 20(4):E5. DOI: 10.3171/foc.2006.20.4.2. View